Wei Dong Wang
Fortune : 97 M $ au 30/09/2026
Fortune : 97 M $ au 30/09/2026
Wei Dong Wang is the founder of Yantai Rongchang Pharmaceutical Co. Ltd., founded in 1993, holding the title of Chairman since 1993.
Mr. Wang is the founder of RemeGen Co., Ltd., founded in 2008, holding the title of Chairman since 2019.
Mr. Wang currently holds the position of Director at MabPlex International Co., Ltd. since 2013.
Mr. Wang completed an undergraduate degree at Harbin University of Commerce in 1982.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2026 | 4 111 338 ( 1,16% ) | 72 M $ | 30/09/2026 | |
| 22/07/2026 | 2 545 541 ( 1,22% ) | 25 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REMEGEN CO., LTD. | Fondateur | 04/07/2008 |
Yantai Rongchang Pharmaceutical Co. Ltd. | Fondateur | 01/03/1993 |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and sale of antibody drugs | Directeur/Membre du Conseil | 25/06/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Harbin University of Commerce
Harbin University of Commerce Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and sale of antibody drugs | Health Technology |
RemeGen Co., Ltd.
RemeGen Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Health Technology |
Yantai Rongchang Pharmaceutical Co. Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national